More people survive cancer: 7 lessons from Europe for NHS
Discover which European country helps more people survive cancer and what key lessons the NHS can adopt. Learn about the 7 strategies for better outcomes and care.
cancer treatment
Read More
PD-L1xVEGF Drug: 1st Global Data for SCLC from BioNTech
BioNTech and BMS reveal promising first global data for their new pd-l1xvegf drug, a novel bispecific antibody targeting Small Cell Lung Cancer (SCLC) patients.
PD-L1xVEGF Bispecific: 1st Global Data from BioNTech/BMS
BioNTech and BMS reveal promising first-in-human global data for their novel PD-L1xVEGF bispecific antibody, showing potential in treating advanced solid tumors.
new promising os trend: Summit’s Phase 3 global data
Explore the latest global data from Summit’s PD-1xVEGF clinical trial, revealing a new promising OS trend for patients. See how this breakthrough could change care.